# The TransCatheter Valve and Vessels Trial

Study · id `cardio:ct-nct03424941` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03424941](<https://clinicaltrials.gov/study/NCT03424941>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03424941

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.

## Technical summary

Registry record NCT03424941. Randomized; no masking; primary purpose treatment. Start 2018-05-31 (actual); primary completion 2024-06-26 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 172 participants (enrolled count; ClinicalTrials.gov record NCT03424941, source copy `cardio:ctgov-nct03424941-2025-01-09`, retrieved 2026-10-26)
- Started: 2018-05-31 (actual) (ClinicalTrials.gov record NCT03424941, source copy `cardio:ctgov-nct03424941-2025-01-09`, retrieved 2026-10-26)
- Primary completion: 2024-06-26 (actual) (ClinicalTrials.gov record NCT03424941, source copy `cardio:ctgov-nct03424941-2025-01-09`, retrieved 2026-10-26)
- Completion: 2024-06-26 (actual) (ClinicalTrials.gov record NCT03424941, source copy `cardio:ctgov-nct03424941-2025-01-09`, retrieved 2026-10-26)
- Countries: Austria; Denmark; France; Germany; Greece; Netherlands; Poland; Portugal; Slovakia; Spain (ClinicalTrials.gov record NCT03424941, source copy `cardio:ctgov-nct03424941-2025-01-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03424941-2025-01-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: The TransCatheter Valve and Vessels Trial
- Acronym: TCW
- Condition: Aortic Stenosis
- Condition: Multi Vessel Coronary Artery Disease
- Condition: TAVI
- Condition: CABG
- Condition: PCI
- Condition: Fractional Flow Reserve
- Intervention (Device): FFR-guided PCI and TAVI
- Intervention (Device): CABG and SAVR
- Lead sponsor: Maatschap Cardiologie Zwolle
- Lead sponsor class: OTHER
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial (`cardio:pubmed-39644913`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 309a10c518268e8271f8e1a5f6a6961678d049ab76b78d1c9fd5d38562c63b73
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
